Medical Treatment Guidelines for Acute Migraine Attacks.

作者
Yung‐Chu Hsu,Kao‐Chang Lin,Treatment Guideline Subcommittee Of Taiwan Headache Society Taiwan Headache Society
出处
期刊:PubMed [National Institutes of Health]
卷期号:26 (2): 78-96 被引量:11
链接
标识
摘要

In 2015, the American Headache Society (AHS) amended the treatment guideline of acute migraine based on evidence-based medicine (EBM) that all triptans in any form of preparations, acetaminophen, and non-steroid anti-inflammation drugs-NSAID (aspirin, diclofenac, ibuprofen, naproxen), sumatriptan/naproxen, combined acetaminophen/aspirin/caffeine are considered effective (Level A). Previously effective drugs as prochlorperazine, and dihydroergotamine-DHE (excluded inhaled form) were downrated to probable effective (Level B). Taiwan Headache Society published its treatment guideline for acute migraine attack in 2007. It should be updated based on the new available evidence. The Treatment Guideline Subcommittee of Taiwan Headache Society reviewed the recent trials, evaluated the grade of evidence, and appraised the clinical efficacy to reach a new consensus. We also referred to the guidelines from United States, Europe, Canada and other countries to make this one meets our needs and feasible. Acute medications currently available in Taiwan can be categorized into "migraine-specific"and"migraine-nonspecific" groups. Migraine-specific triptans and migraine-nonspecific nonsteroidal antiinflammatory drugs (NSAIDs) have the best levels of evidence, and are recommended as the first-line medications for acute migraine attacks. The administration should follow the concept of "stratified care". For mild to moderate migraine attacks, oral NSAIDs are the first choice; with oral aspirin, combination analgesics, intravenous/intramuscular NSAIDs as alternatives. For moderate to severe attacks, oral or nasal spray triptans and ergotamine/caffeine compounds are recommended and should be administered in the early stage of migraine attacks. Antiemetics can be used as supplement to alleviate nausea and vomiting. Notably, a combination of a triptan and a NSAID yielded a better efficacy compared with either therapy alone. Parenteral steroid and fluid supply are the first choice in treatment of status migrainosus. Acetaminophen is suitable for mild to moderate migraine attacks and remains the first choice for children and pregnant women. Opiates are not recommended for acute migraine treatment at the present time because of serious adverse events. To prevent medication-overuse headache, the use of acute treatment should be limited to a maximum of ten days a month.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
忧虑的摇伽完成签到,获得积分10
1秒前
1秒前
hh完成签到,获得积分10
1秒前
要减肥香萱完成签到 ,获得积分10
1秒前
2秒前
鱼卷完成签到,获得积分10
2秒前
CTShih完成签到,获得积分10
3秒前
SCL987654321发布了新的文献求助10
3秒前
3秒前
4秒前
李健的应助被美丽采纳,获得20
4秒前
所所的应助被小鱼采纳,获得10
4秒前
4秒前
爱笑的灵阳完成签到 ,获得积分10
5秒前
tyr111完成签到,获得积分10
6秒前
6秒前
张远幸发布了新的文献求助10
6秒前
忙与闲都伤完成签到,获得积分10
7秒前
Colin完成签到,获得积分10
8秒前
缓慢半山发布了新的文献求助10
8秒前
能干储完成签到,获得积分10
8秒前
9秒前
脑洞疼的应助被zzz采纳,获得10
9秒前
财务自由完成签到,获得积分10
9秒前
大大彬完成签到 ,获得积分10
9秒前
9秒前
科研通AI65的应助被SCL987654321采纳,获得10
9秒前
鱼卷发布了新的文献求助10
10秒前
顾矜的应助被mm采纳,获得10
10秒前
吴境发布了新的文献求助10
10秒前
今后的应助被JF123_采纳,获得10
10秒前
加菲丰丰的应助被yangfan采纳,获得30
11秒前
Li完成签到 ,获得积分10
11秒前
温柔的契完成签到,获得积分10
11秒前
12秒前
NN完成签到,获得积分10
12秒前
情怀的应助被王海钰采纳,获得10
12秒前
12秒前
蛋又白发布了新的文献求助10
12秒前
听话的老太完成签到,获得积分10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187362
求助须知:如何正确求助?哪些是违规求助? 9575478
关于积分的说明 21841431
捐赠科研通 7785067
什么是DOI,文献DOI怎么找? 3434943
关于科研通互助平台的介绍 2559401
邀请新用户注册赠送积分活动 2481820